


Healthcare News Roundup: Neuro
HSMN NewsFeed - 20 Feb 2014
Nexstim Announces Publication of a Landmark Study Showing Preoperative NBS Mapping Improves Patient Outcome
Nexstim Announces Publication of a Landmark Study Showing Preoperative NBS Mapping Improves Patient Outcome
HSMN NewsFeed - 17 Feb 2014
Neurovive Pharmaceutical: NeuroVive Treats Final Patient in European Phase III Trial on CicloMulsion(R)
Neurovive Pharmaceutical: NeuroVive Treats Final Patient in European Phase III Trial on CicloMulsion(R)
HSMN NewsFeed - 11 Feb 2014
Former Amgen Finance Executive Carl Adams Joins NeuroSigma As Vice President and Controller
Former Amgen Finance Executive Carl Adams Joins NeuroSigma As Vice President and Controller
HSMN NewsFeed - 28 Jan 2014
Teva Announces U.S. FDA Approval of Three-Times-a-Week COPAXONE(R) (glatiramer acetate injection) 40mg/mL
Teva Announces U.S. FDA Approval of Three-Times-a-Week COPAXONE(R) (glatiramer acetate injection) 40mg/mL
HSMN NewsFeed - 28 Jan 2014
Kiva(R) VCF Treatment System Receives FDA Clearance For Vertebral Compression Fractures
Kiva(R) VCF Treatment System Receives FDA Clearance For Vertebral Compression Fractures
HSMN NewsFeed - 27 Jan 2014
Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director
Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director
HSMN NewsFeed - 21 Jan 2014
NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquired by Teva
NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquired by Teva
HSMN NewsFeed - 13 Jan 2014
Mallinckrodt Pharmaceuticals and Medtronic Announce Clinical and Commercial Collaboration
Mallinckrodt Pharmaceuticals and Medtronic Announce Clinical and Commercial Collaboration
HSMN NewsFeed - 6 Jan 2014
Stryker and NeuroLogica Partner to Provide Surgical Navigation with the BodyTom(R) Portable CT Scanner
Stryker and NeuroLogica Partner to Provide Surgical Navigation with the BodyTom(R) Portable CT Scanner
HSMN NewsFeed - 3 Jan 2014
RegeneRx Receives Orphan Drug Designation for Tβ4 in the Treatment of Neurotrophic Keratopathy
RegeneRx Receives Orphan Drug Designation for Tβ4 in the Treatment of Neurotrophic Keratopathy
HSMN NewsFeed - 31 Dec 2013
Agilis Biotherapeutics Completes $8 Million Financing to Develop DNA-based Therapeutics for Rare Diseases
Agilis Biotherapeutics Completes $8 Million Financing to Develop DNA-based Therapeutics for Rare Diseases
HSMN NewsFeed - 30 Dec 2013
Genzyme Receives Complete Response Letter from FDA on Lemtrada(TM) (alemtuzumab) Application
Genzyme Receives Complete Response Letter from FDA on Lemtrada(TM) (alemtuzumab) Application
